AnaptysBio
ANAB
ANAB
146 hedge funds and large institutions have $812M invested in AnaptysBio in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 31 closing their positions.
Holders
146
Holders Change
-7
Holders Change %
-4.58%
% of All Funds
1.96%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
27
Increased
44
Reduced
55
Closed
31
Calls
$2.17M
Puts
$734K
Net Calls
+$1.43M
Net Calls Change
+$874K
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$41.5M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$28.2M |
| 3 |
3
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$8.18M |
| 4 |
6CM
4
683 Capital Management
New York
|
$11.1M |
| 5 |
NL
5
Nuveen LLC
Charlotte,
North Carolina
|
$7.18M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TPCW
176
TD Private Client Wealth
New York
| – | – | -27 | Closed |
|
|
CFD
177
Creative Financial Designs
Kokomo,
Indiana
| – | – | -16 | Closed |
|
|
C
178
Covestor
London,
United Kingdom
| $0 | 5 | -1 | -17% |
|
|
DP
179
Diadema Partners
Morristown,
New Jersey
| – | – | – | – |
|
180
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
181
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
PAP
182
Persistent Asset Partners
Hong Kong
| – | – | – | – |
|